Details for New Drug Application (NDA): 020551
✉ Email this page to a colleague
The generic ingredient in NIMBEX PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 020551
Tradename: | NIMBEX PRESERVATIVE FREE |
Applicant: | Abbvie |
Ingredient: | cisatracurium besylate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Dec 15, 1995 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
Approval Date: | Dec 15, 1995 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
Approval Date: | Dec 15, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 020551
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | NIMBEX PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 020551-002 | Dec 15, 1995 | 4,179,507 | ⤷ Subscribe |
Abbvie | NIMBEX | cisatracurium besylate | INJECTABLE;INJECTION | 020551-001 | Dec 15, 1995 | 4,179,507 | ⤷ Subscribe |
Abbvie | NIMBEX PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 020551-002 | Dec 15, 1995 | 5,453,510 | ⤷ Subscribe |
Abbvie | NIMBEX PRESERVATIVE FREE | cisatracurium besylate | INJECTABLE;INJECTION | 020551-003 | Dec 15, 1995 | 5,453,510 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription